Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Human Genetics and Genomic Medicine, |
RCV002226629 | SCV002505378 | uncertain significance | Combined oxidative phosphorylation deficiency 55 | 2022-04-25 | criteria provided, single submitter | clinical testing | The detected change is reported in the dbSNP database (dbSNP151 as of 04/25/2022) with the designation rs566027653. In gnomAD it is listed with a frequency of 0.01203% (34/282580) (as of April 25, 2022). Bioinformatically, the change is inconsistently classified as "probably disease-causing" (CADDphred 25.2) or as more benign (MutationTaster). Since this is a highly conserved amino acid, the variant may have an influence on the function of the protein. Based on the current state of knowledge, the variant can be classified as a “variant of uncertain clinical significance” (ACMG criteria). |